Fig 1.
An Xpert-based algorithm for diagnosing DR-TB among high-risk populations.
Table 1.
Xpert and LPA results for high-risk DR populations.
Table 2.
Performance of the Xpert test for the detection of MTBC, compared to smear and culture results.
Table 3.
Xpert and LPA results for drug resistance detection, compared to conventional DST results.
Table 4.
Xpert and LPA probe hybridization patterns.